REPETTO, MATTEO

REPETTO, MATTEO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A dynamic approach to supply chain reconfiguration and ripple effect analysis in an epidemic 2023 La Torre D.Repetto M. + Article (author) -
A robust goal programming model for transfer pricing risk hedging: Preliminary results 2019 Repetto M.La Torre D.Liuzzi D. Book Part (author) -
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 2022 Mazzarella, LGiugliano, FNicolo', ECrimini, EUliano, JCorti, CRepetto, MAntonarelli, GAscione, LVivanet, GCriscitiello, CCurigliano, G + Article (author) -
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research 2021 Repetto M.Curigliano G. + Article (author) -
High-performance prediction models for prostate cancer radiomics 2023 Isaksson L. J.Repetto M.Pepa M.Zaffaroni M.Mazzola G. C.Rotondi M.Bellerba F.Pricolo P.Mistretta F. A.Luzzago S.Musi G.De Cobelli O.Orecchia R.La Torre D.Marvaso G.Petralia G.Jereczek-Fossa B. A. + Article (author) -
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 2021 Giugliano, FCrimini, EUliano, JCorti, CRepetto, MAntonarelli, GVivanet, GCriscitiello, CCurigliano, G + Article (author) -
Precision medicine in breast cancer : From clinical trials to clinical practice 2021 Crimini, EdoardoRepetto, MatteoCurigliano, Giuseppe + Article (author) -
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies 2021 Antonarelli G.Giugliano F.Corti C.Repetto M.Curigliano G. + Article (author) -
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 2021 Repetto M.Crimini E.Giugliano F.Morganti S.Curigliano G. + Article (author) -
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 2021 Crimini E.Corti C.Repetto M.Giugliano F.Antonarelli G.Zagami P.Morganti S.Uliano J.Curigliano G. + Article (author) -
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 2022 Mazzarella LCrimini EUliano JCorti CTrillo Aliaga PRepetto MAntonarelli GCriscitiello CCurigliano G. + Article (author) -
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy 2021 Repetto, MCalvello, MCatania, CCurigliano, G + Article (author) -